Skip to main content
Premium Trial:

Request an Annual Quote

AssureRx Updates GeneSightRx Panel with New Gene: CYP1A2

Premium

Originally published March 8.

AssureRx has added a fifth gene, CYP1A2, to its laboratory-developed pharmacogenomic test GeneSightRx, the company announced this week.

GeneSightRx, which also analyzes CYP2D6, CYP2C19, the serotonin transporter gene SLC6A4, and the serotonin 2A receptor gene 5HTR2A, operates on the Luminex 200 platform using the xTag process. When AssureRx first launched the test in late 2009, the company described it as a "multivariate, algorithmic, interpretive" test that will guide psychiatric treatment decisions [see PGx Reporter 10-27-2009].

According to the company, GeneSightRx analyzes more than forty gene variants that affect patients' response to certain psychiatric drugs, including antidepressants and antipsychotics.

"GeneSightRx integrates the analysis of genes and their many variations to obtain an evidence-based pharmacogenetic profile," the company notes. "The gene variations are further analyzed against 26 FDA-approved drugs to help physicians select patient-appropriate psychotropic medications."

According to PharmGKB, the online pharmacogenomics information database, CYP2A2 variations have been associated in studies with response to the antianxiety drug alpraxolam, the antidepressant citalopram, and the schizophrenia drug clozapin, among others.

The Mayo Clinic and the Cincinnati Children's Hospital Medical Center were early-access users of GeneSightRx before its commercial launch.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.